SE8704272D0 - Pharmaceutisk komposition - Google Patents

Pharmaceutisk komposition

Info

Publication number
SE8704272D0
SE8704272D0 SE8704272A SE8704272A SE8704272D0 SE 8704272 D0 SE8704272 D0 SE 8704272D0 SE 8704272 A SE8704272 A SE 8704272A SE 8704272 A SE8704272 A SE 8704272A SE 8704272 D0 SE8704272 D0 SE 8704272D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
dithia
azaspiro
alanyl
phenylpropyl
Prior art date
Application number
SE8704272A
Other languages
English (en)
Other versions
SE8704272L (sv
Inventor
H Siegl
R P Hof
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626217A external-priority patent/GB8626217D0/en
Priority claimed from GB878713349A external-priority patent/GB8713349D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8704272D0 publication Critical patent/SE8704272D0/sv
Publication of SE8704272L publication Critical patent/SE8704272L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8704272A 1986-11-03 1987-11-02 Pharmaceutisk komposition SE8704272L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868626217A GB8626217D0 (en) 1986-11-03 1986-11-03 Pharmaceutical compositions
GB878713349A GB8713349D0 (en) 1987-06-08 1987-06-08 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
SE8704272D0 true SE8704272D0 (sv) 1987-11-02
SE8704272L SE8704272L (sv) 1988-05-04

Family

ID=26291485

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8704272A SE8704272L (sv) 1986-11-03 1987-11-02 Pharmaceutisk komposition

Country Status (25)

Country Link
KR (1) KR960005145B1 (sv)
AT (1) AT397343B (sv)
AU (1) AU615883B2 (sv)
BE (1) BE1002063A4 (sv)
CA (1) CA1314222C (sv)
CH (1) CH677189A5 (sv)
DE (1) DE3736505A1 (sv)
DK (1) DK574087A (sv)
ES (1) ES2010524A6 (sv)
FI (1) FI874823A (sv)
FR (1) FR2605885B1 (sv)
GR (1) GR871680B (sv)
HK (1) HK138893A (sv)
HU (1) HU199681B (sv)
IE (1) IE60496B1 (sv)
IL (1) IL84343A (sv)
IT (1) IT1212037B (sv)
LU (1) LU87034A1 (sv)
MY (1) MY102124A (sv)
NL (1) NL8702502A (sv)
NO (1) NO874539L (sv)
NZ (1) NZ222401A (sv)
PH (1) PH23249A (sv)
PT (1) PT86062B (sv)
SE (1) SE8704272L (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
FR2733911B1 (fr) * 1995-05-09 1998-05-29 Takeda Chemical Industries Ltd Composition pharmaceutique pour maladies renales ou cardio-vasculaires

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
US4520021A (en) * 1982-07-02 1985-05-28 Merck & Co., Inc. Substituted caprolactam derivatives as antihypertensives
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
GB2198641B (en) * 1986-11-03 1990-09-19 Sandoz Ltd Pharmaceutical composition for use against hypertension and congestive heart failure
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor

Also Published As

Publication number Publication date
HUT47847A (en) 1989-04-28
GR871680B (en) 1988-05-02
FR2605885A1 (fr) 1988-05-06
NO874539L (no) 1988-05-04
FI874823A (fi) 1988-05-04
HU199681B (en) 1990-03-28
AU8057687A (en) 1988-05-05
PT86062B (pt) 1990-11-07
IL84343A0 (en) 1990-02-09
ES2010524A6 (es) 1989-11-16
IL84343A (en) 1993-07-08
KR960005145B1 (ko) 1996-04-22
CA1314222C (en) 1993-03-09
CH677189A5 (sv) 1991-04-30
DK574087A (da) 1988-05-04
NZ222401A (en) 1991-04-26
ATA286987A (de) 1993-08-15
IE872951L (en) 1988-05-03
PH23249A (en) 1989-06-16
MY102124A (en) 1992-03-31
PT86062A (en) 1987-12-01
AU615883B2 (en) 1991-10-17
LU87034A1 (fr) 1988-05-03
IE60496B1 (en) 1994-07-27
IT1212037B (it) 1989-11-08
SE8704272L (sv) 1988-05-04
FR2605885B1 (fr) 1993-09-10
NO874539D0 (no) 1987-11-02
DK574087D0 (da) 1987-11-02
FI874823A0 (fi) 1987-11-02
BE1002063A4 (fr) 1990-06-12
IT8748553A0 (it) 1987-10-30
HK138893A (en) 1993-12-24
DE3736505A1 (de) 1988-05-05
NL8702502A (nl) 1988-06-01
AT397343B (de) 1994-03-25
KR880006197A (ko) 1988-07-22

Similar Documents

Publication Publication Date Title
SG52709A1 (en) Substituted imidazoles
BG103143A (en) Substituted pyrido- or pirimidocontaining 6,6- or 6,7-bicyclic derivatives
IT8520023A0 (it) 1-(idrossometil)-1,6,7,11b-tetraidro-2h,4h-(1,3)-ossazinooppure-tiazino(4,3-a)isochinolin-de rivati, procedimento per la loro prepazione e composizioni farmaceutiche che li contengono.
MX9706957A (es) Composicion que contiene amlodipina, o una sal, o felodipina y un inhibidor de enzima convertidora de angiotensina.
UA26845C2 (uk) Похідhі пептидів, що є аhтагоhістами речовиhи р та hейрокіhіhу а
DE3571438D1 (en) Substituted hexahydro arylquinolizines
SE8704272L (sv) Pharmaceutisk komposition
BR9714376A (pt) Antagonistas de somatostatina
IT8222759A0 (it) 2-(omega -alchilaminoalchil)- e 2 (omega - dialchilaminoalchil) - 3- - (4 -x-benzilidene) ftalimidine, procedimento per la loro preparazione e loro impiego.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
GR862285B (en) Pharmaceutical compositions for treating the high blood pressure
BG103859A (en) The use of 1-ar(alk)yl-imidazolin-2-on for the treatment of fear and stress conditions
DK0609242T3 (da) Nyt thrombininhibitorisk protein fra blodmider
DK541789D0 (da) Farmaceutisk praeparat indeholdende 5-t-butyl-3-oen-(1-(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanylaa-2,3-dihydro-1,3,4-thiadiazol-2-(s)-carboxylsyre eller derivater deraf, og fremgangsmaade til dets fremstilling
FI893211A0 (fi) Antihypertensiva, n-terminala eteraminodiolamino-syraderivat.
GB9014705D0 (en) Pharmaceutical composition for use against hypertension and congestive heart failure
DE68905343D1 (de) Dosisform zur verabreichung von calciumantagonisten.
ATE84794T1 (de) Aminosaeure-derivate als antihypertensive.
ATE102035T1 (de) Verwendung von 5-heteroaryl- oder 5arylsubstituierten imidazo(2,1-a)isochinolinen.
IT8619931A0 (it) Procedimento per la preparazione della 1-(n-metilamidino)-3-(2,6-dimetilfe nil) urea e dei suoi sali farmaceuticamente accettabili.